Remote Patient Monitoring for Managing Interstitial Lung DiseaseTake-Home Points
Background: Hybrid health care delivery uses a combination of in-person and telehealth visits to deliver interstitial lung disease (ILD) care efficiently and flexibly. However, assessments of ILD activity and progression can be limited during telehealth visits. Remote patient monitoring (RPM) is an...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-03-01
|
| Series: | CHEST Pulmonary |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2949789224000886 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849711449301057536 |
|---|---|
| author | Genevieve Gillett, MD Rupal J. Shah, MD Alison M. DeDent, MD Erica Farrand, MD |
| author_facet | Genevieve Gillett, MD Rupal J. Shah, MD Alison M. DeDent, MD Erica Farrand, MD |
| author_sort | Genevieve Gillett, MD |
| collection | DOAJ |
| description | Background: Hybrid health care delivery uses a combination of in-person and telehealth visits to deliver interstitial lung disease (ILD) care efficiently and flexibly. However, assessments of ILD activity and progression can be limited during telehealth visits. Remote patient monitoring (RPM) is an effective approach to evaluating ILD trajectories. However, in the United States, there has been limited uptake of RPM into ILD care models. Research Question: Can we define patient-level facilitators and barriers to implementing RPM into routine ILD care? Study Design and Methods: RPM data from spirometers and pulse oximeters were collected weekly from participants with newly diagnosed ILD. Additional data were collected using surveys and qualitative interviews in a parallel convergent mixed-methods design, reflexively analyzed for themes, and integrated using a triangulation protocol. Results: Sixty participants had a median age of 74 years; most were male (59%), White (60.7%), and diagnosed with idiopathic pulmonary fibrosis (50%). Adherence to weekly device use was high (90%) and participants thought RPM was an important (90%) and sustainable (87%) part of ILD care. Key barriers to RPM use included difficulty with spirometry technique, communication of results, and result interpretation. Interpretation: Our results indicate that RPM is a feasible, valuable, and sustainable component of routine ILD care. Applying an implementation science framework, patient-level barriers would be best addressed through (1) supervised device setup, (2) more efficient and frequent communication, and (3) improved patient education. Addressing these barriers may facilitate more widespread and successful implementation of RPM, with the potential to greatly improve patient engagement in ILD care. |
| format | Article |
| id | doaj-art-d469c31cb9c949faacf8ccd3dea3adc7 |
| institution | DOAJ |
| issn | 2949-7892 |
| language | English |
| publishDate | 2025-03-01 |
| publisher | Elsevier |
| record_format | Article |
| series | CHEST Pulmonary |
| spelling | doaj-art-d469c31cb9c949faacf8ccd3dea3adc72025-08-20T03:14:38ZengElsevierCHEST Pulmonary2949-78922025-03-013110012210.1016/j.chpulm.2024.100122Remote Patient Monitoring for Managing Interstitial Lung DiseaseTake-Home PointsGenevieve Gillett, MD0Rupal J. Shah, MD1Alison M. DeDent, MD2Erica Farrand, MD3Interstitial Lung Disease Program, Department of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco, CA; Albert Einstein College of Medicine, New York, NY; CORRESPONDENCE TO: Genevieve GillettInterstitial Lung Disease Program, Department of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco, CAInterstitial Lung Disease Program, Department of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco, CAInterstitial Lung Disease Program, Department of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco, CABackground: Hybrid health care delivery uses a combination of in-person and telehealth visits to deliver interstitial lung disease (ILD) care efficiently and flexibly. However, assessments of ILD activity and progression can be limited during telehealth visits. Remote patient monitoring (RPM) is an effective approach to evaluating ILD trajectories. However, in the United States, there has been limited uptake of RPM into ILD care models. Research Question: Can we define patient-level facilitators and barriers to implementing RPM into routine ILD care? Study Design and Methods: RPM data from spirometers and pulse oximeters were collected weekly from participants with newly diagnosed ILD. Additional data were collected using surveys and qualitative interviews in a parallel convergent mixed-methods design, reflexively analyzed for themes, and integrated using a triangulation protocol. Results: Sixty participants had a median age of 74 years; most were male (59%), White (60.7%), and diagnosed with idiopathic pulmonary fibrosis (50%). Adherence to weekly device use was high (90%) and participants thought RPM was an important (90%) and sustainable (87%) part of ILD care. Key barriers to RPM use included difficulty with spirometry technique, communication of results, and result interpretation. Interpretation: Our results indicate that RPM is a feasible, valuable, and sustainable component of routine ILD care. Applying an implementation science framework, patient-level barriers would be best addressed through (1) supervised device setup, (2) more efficient and frequent communication, and (3) improved patient education. Addressing these barriers may facilitate more widespread and successful implementation of RPM, with the potential to greatly improve patient engagement in ILD care.http://www.sciencedirect.com/science/article/pii/S2949789224000886implementation scienceinterstitial lung diseaseremote patient monitoring |
| spellingShingle | Genevieve Gillett, MD Rupal J. Shah, MD Alison M. DeDent, MD Erica Farrand, MD Remote Patient Monitoring for Managing Interstitial Lung DiseaseTake-Home Points CHEST Pulmonary implementation science interstitial lung disease remote patient monitoring |
| title | Remote Patient Monitoring for Managing Interstitial Lung DiseaseTake-Home Points |
| title_full | Remote Patient Monitoring for Managing Interstitial Lung DiseaseTake-Home Points |
| title_fullStr | Remote Patient Monitoring for Managing Interstitial Lung DiseaseTake-Home Points |
| title_full_unstemmed | Remote Patient Monitoring for Managing Interstitial Lung DiseaseTake-Home Points |
| title_short | Remote Patient Monitoring for Managing Interstitial Lung DiseaseTake-Home Points |
| title_sort | remote patient monitoring for managing interstitial lung diseasetake home points |
| topic | implementation science interstitial lung disease remote patient monitoring |
| url | http://www.sciencedirect.com/science/article/pii/S2949789224000886 |
| work_keys_str_mv | AT genevievegillettmd remotepatientmonitoringformanaginginterstitiallungdiseasetakehomepoints AT rupaljshahmd remotepatientmonitoringformanaginginterstitiallungdiseasetakehomepoints AT alisonmdedentmd remotepatientmonitoringformanaginginterstitiallungdiseasetakehomepoints AT ericafarrandmd remotepatientmonitoringformanaginginterstitiallungdiseasetakehomepoints |